Senior Director, Clinical Development - Dermatology (MD)

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers.

We set and achieve bold ambitions in our fight against the world's most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come.

This role requires regular on-site presence in Foster City, CA and is not eligible for remote or hybrid work arrangements. Applicants must currently reside in the area or be willing to relocate to Foster City prior to their start date. Local candidates are strongly encouraged to apply.

The Senior Director, Clinical Development will provide clinical and scientific leadership for inflammation development programs, with particular emphasis on immune-mediated inflammatory diseases and dermatology. The successful candidate will play a key role in defining development strategy, translating emerging biology into clinical hypotheses, and designing clinical programs capable of generating clear, decision-enabling evidence.

This individual will work across functions and programs, helping shape both individual asset strategies and the broader inflammation portfolio. The role requires substantive experience establishing and leading Phase 2 development programs, with the strategic perspective needed to build programs that can transition efficiently into Phase 3 and support registration.

Key Responsibilities

· Provide clinical and scientific leadership for one or more inflammation development programs, with opportunities spanning dermatologic, respiratory, and other immune-mediated diseases.

· Lead development and continual refinement of Clinical Development Plans (CDPs), including indication strategy, target populations, clinical sequencing, differentiation strategy, success criteria, and key development decisions.

· Lead the strategy, design, initiation, execution, and interpretation of Phase 2 clinical development programs, including proof-of-concept and dose-ranging studies, with an eye toward Phase 3 and registration.

· Own key elements of Phase 2 program development, including clinical strategy, protocol development, patient population, endpoints, dose and regimen selection, and medical input into site and investigator selection.

· Provide medical and scientific leadership during study start-up and execution, including investigator and site selection strategy, site initiation, investigator engagement, enrollment, protocol interpretation, and ongoing assessment of study conduct.

· Use emerging Phase 2 data to refine the development strategy and prepare successful programs for transition into Phase 3 and registrational development.

· Translate complex immunology, human genetics, translational science, and disease biology into testable clinical hypotheses and development strategies.

· Integrate clinical, translational, biomarker, pharmacologic, competitive, and emerging external data to inform asset and portfolio strategy.

· Provide senior medical leadership for protocols, eligibility criteria, endpoints, safety monitoring, dose selection, benefit-risk assessment, and interpretation of clinical data.

· Apply a strong understanding of dermatologic disease biology and clinical development to programs in areas such as atopic dermatitis, hidradenitis suppurativa, psoriasis, and related immune-mediated diseases, while contributing broadly across the inflammation portfolio.

· Identify opportunities for differentiation based on mechanism, patient population, clinical endpoints, treatment setting, and evolving standards of care.

…